Blood vessel maturation and response to vascular-disrupting therapy in single vascular endothelial growth factor-A isoform-producing tumors.
about
Formation of VEGF isoform-specific spatial distributions governing angiogenesis: computational analysisWhy are tumour blood vessels abnormal and why is it important to know?Extracellular regulation of VEGF: isoforms, proteolysis, and vascular patterning.3-D photoacoustic and pulse echo imaging of prostate tumor progression in the mouse window chamber.In vivo microcartography and subcellular imaging of tumor angiogenesis: a novel platform for translational angiogenesis research.Anchorage of VEGF to the extracellular matrix conveys differential signaling responses to endothelial cells.In vivo spectral and fluorescence microscopy comparison of microvascular function after treatment with OXi4503, Sunitinib and their combination in Caki-2 tumors.Functional and structural characteristics of tumor angiogenesis in lung cancers overexpressing different VEGF isoforms assessed by DCE- and SSCE-MRI.Increased vascular delivery and efficacy of chemotherapy after inhibition of platelet-derived growth factor-BTumour cells expressing single VEGF isoforms display distinct growth, survival and migration characteristicsDo anti-angiogenic VEGF (VEGFxxxb) isoforms exist? A cautionary taleIn vivo functional differences in microvascular response of 4T1 and Caki-1 tumors after treatment with OXi4503Influence of soluble or matrix-bound isoforms of vascular endothelial growth factor-A on tumor response to vascular-targeted strategies.An in vivo role for Rho kinase activation in the tumour vascular disrupting activity of combretastatin A-4 3-O-phosphate.PhagoSight: an open-source MATLAB® package for the analysis of fluorescent neutrophil and macrophage migration in a zebrafish model.Recombinant " IMS TAG" proteins--a new method for validating bottom-up matrix-assisted laser desorption/ionisation ion mobility separation mass spectrometry imaging.Targeting the tumour vasculature: exploitation of low oxygenation and sensitivity to NOS inhibition by treatment with a hypoxic cytotoxin.MALDI-MSI and label-free LC-ESI-MS/MS shotgun proteomics to investigate protein induction in a murine fibrosarcoma model following treatment with a vascular disrupting agent.Regioselective synthesis of water-soluble monophosphate derivatives of combretastatin A-1.MDA-MB-231 breast cancer cells overexpressing single VEGF isoforms display distinct colonisation characteristics.Predicting the effects of anti-angiogenic agents targeting specific VEGF isoforms.The isoflavone metabolite 6-methoxyequol inhibits angiogenesis and suppresses tumor growth.Autocrine functions of VEGF in breast tumor cells: adhesion, survival, migration and invasion.Effect of tumor microenvironment on tumor VEGF during anti-VEGF treatment: systems biology predictionsTumour vascular disrupting agents: combating treatment resistance.Combination of antiangiogenesis with chemotherapy for more effective cancer treatment.Microtubule depolymerizing vascular disrupting agents: novel therapeutic agents for oncology and other pathologies.Synthesis of structurally diverse benzosuberene analogues and their biological evaluation as anti-cancer agents.Pericyte-targeting prodrug overcomes tumor resistance to vascular disrupting agents.CAPER-α alternative splicing regulates the expression of vascular endothelial growth factor₁₆₅ in Ewing sarcoma cells.B-ring-modified isocombretastatin A-4 analogues endowed with interesting anticancer activities.Concise syntheses of N-aryl-5,6,7-trimethoxyindoles as antimitotic and vascular disrupting agents: application of the copper-mediated Ullmann-type arylation.2-amino-3,4,5-trimethoxybenzophenones as potent tubulin polymerization inhibitors.Vascular effects dominate solid tumor response to treatment with combretastatin A-4-phosphate.The protective role of sphingosine-1-phosphate against the action of the vascular disrupting agent combretastatin A-4 3-O-phosphate.Vascular patterning of subcutaneous mouse fibrosarcomas expressing individual VEGF isoforms can be differentiated using angiographic optical coherence tomography.Transmission and scanning electron microscopy study of the characteristics and morphology of pericytes and novel desmin-immunopositive perivascular cells before and after castration in rat anterior pituitary gland.An automatic algorithm for the segmentation and morphological analysis of microvessels in immunostained histological tumour sections.An Improved In Vivo Methodology to Visualise Tumour Induced Changes in Vasculature Using the Chick Chorionic Allantoic Membrane Assay.
P2860
Q21202775-EDF37198-91E7-48AC-8E30-CF2D054E4869Q24652018-BA5AB95E-AEB5-4CC0-8864-199B1F949BC1Q27000351-483CF22D-35CF-4FC5-B2D4-469430E5A181Q30470306-F2EECE8A-5A49-440E-AF93-B577AA7B3B2AQ30490037-431B4BE9-FE68-4A54-A4DC-46D493F04FF1Q33689582-89336F5B-E0D1-4046-890F-464D6E9735BBQ33738607-0CD0353D-BD3B-4E48-A9FA-594991376658Q33809311-CF2BD18D-6A55-4608-BC2A-10C2E170CEDDQ33922852-6D85835E-E17D-4140-802A-5EF5081E4626Q34041280-E2C60B8F-910D-4DDF-8A0E-0A157999D3B9Q34261539-AAE856F6-A13A-40C2-9F91-511AA171CF8CQ34296779-F9A08959-BD3B-43AB-8FA6-8B36090B6061Q34742649-4CF35D29-8DA7-44C4-8031-DD1BB1040EABQ34954063-4FE302EB-7C90-4A33-A0E0-2F9582566B5FQ34983558-D5F9171F-5130-4A61-81B6-D1F14BCE7AEBQ35008685-880177C7-434A-49F5-A795-E2D767C3C15DQ35034825-D0C02F61-545E-48C0-918E-5B800ACF0B0DQ35092529-438E9040-40FB-4326-8CF5-7A5F21838689Q35743971-5AB01520-E7DD-4DDE-AA0F-A23B4EEEB3D9Q36027061-932D7335-3117-4630-AB5A-77F5349EA616Q36065567-9DDBD2A5-B9A6-4E1E-9875-894FC1952B3CQ36123270-7FD95010-9E21-4087-8895-FC725C9E0155Q36542090-76296E6B-B5DC-4098-9A07-D0BFD330154AQ36901312-D998C24B-354A-4E52-97E1-3D498DC07C47Q37280244-5B87D1DB-0996-4C96-A2D7-1309259F7E14Q37346912-39374976-39C6-41AC-88FE-E6076D92A680Q37534993-8D55660C-5901-4FF6-AEF2-825439005691Q37670789-B5B706E8-8944-4E81-84FE-1125D9E03D4FQ38941996-FC068D29-F56E-4797-BABA-ECE26782EE5DQ39456265-C1DC7E1C-0F22-471E-8FD7-EDE588DD0CE8Q39459714-42AC8574-033F-49BA-B2A1-F78E5C2ED409Q39574351-511D0E9A-53F0-40F8-94A4-689744FDD8C1Q39584188-D933D521-5E01-462A-B12D-9AC4564E454CQ39620499-4C1BB36E-9021-42E1-87BE-5515D6738ADCQ46807630-DC1A78A4-D053-40D3-92C7-D79665630761Q47120604-AE1893FA-2F77-4F3D-9DDE-1A6D03EC47D8Q48469966-8841420B-33AB-4C03-B412-5644D82459DCQ48572913-569EDBDE-F4EA-46C1-8CDD-F7437FD58154Q55455405-1AC40275-26C0-436F-A191-C07551756B48
P2860
Blood vessel maturation and response to vascular-disrupting therapy in single vascular endothelial growth factor-A isoform-producing tumors.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Blood vessel maturation and re ...... or-A isoform-producing tumors.
@en
Blood vessel maturation and re ...... or-A isoform-producing tumors.
@nl
type
label
Blood vessel maturation and re ...... or-A isoform-producing tumors.
@en
Blood vessel maturation and re ...... or-A isoform-producing tumors.
@nl
prefLabel
Blood vessel maturation and re ...... or-A isoform-producing tumors.
@en
Blood vessel maturation and re ...... or-A isoform-producing tumors.
@nl
P2093
P4510
P50
P1433
P1476
Blood vessel maturation and re ...... tor-A isoform-producing tumors
@en
P2093
Christopher R Ireson
Chryso Kanthou
David T Shima
Davina J Honess
Gillian M Tozer
Katie L Pettyjohn
Meit A Björndahl
Olga Greco
Paul R Barber
Sally A Hill
P304
P356
10.1158/0008-5472.CAN-07-2011
P407
P4510
P577
2008-04-01T00:00:00Z